Cormorant Asset Management’s Inspire Medical Systems INSP Stock Holding History

Cormorant Asset Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-48,132	Closed	-$11.2M	–	83
2021 Q3	$11.2M	Hold	48,132	–	–	0.46%	51
2021 Q2	$9.3M	Sell	48,132 -36,868	-43%	-$7.31M	0.32%	65
2021 Q1	$17.6M	Sell	85,000 -15,000	-15%	-$3.19M	0.39%	58
2020 Q4	$18.8M	Sell	100,000 -20,000	-17%	-$3.27M	0.45%	50
2020 Q3	$15.5M	Sell	120,000 -27,982	-19%	-$3.08M	0.6%	44
2020 Q2	$12.9M	Sell	147,982 -2,018	-1%	-$155K	0.49%	52
2020 Q1	$9.04M	Sell	150,000 -22,300	-13%	-$1.65M	0.42%	51
2019 Q4	$12.8M	Hold	172,300	–	–	0.51%	48
2019 Q3	$10.5M	Sell	172,300 -27,700	-14%	-$1.82M	0.64%	43
2019 Q2	$12.1M	Sell	200,000 -50,000	-20%	-$2.69M	0.7%	42
2019 Q1	$14.2M	Sell	250,000 -40,239	-14%	-$2.17M	0.96%	33
2018 Q4	$12.3M	Sell	290,239 -9,761	-3%	-$415K	1%	33
2018 Q3	$12.6M	Sell	300,000 -25,000	-8%	-$1.17M	0.82%	34
2018 Q2	$11.6M	Buy	+325,000	New	+$10.5M	0.86%	35

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Cormorant Asset Management's INSP Position: Q4 2021 in Review

Cormorant Asset Management sold out of Inspire Medical Systems (INSP) in Q4 2021, closing a stake of 48,132 shares — an estimated $11.2M sold.

Cormorant Asset Management first reported a position in INSP in Q2 2018 and held it in 14 quarters. The position peaked at $18.8M in Q4 2020. 288 funds tracked by Wall St. Rank hold INSP as of Q4 2021.

Cormorant Asset Management reported no remaining Inspire Medical Systems position as of Q4 2021 after selling out during the quarter.
Cormorant Asset Management sold 48,132 Inspire Medical Systems shares in Q4 2021, an estimated $11.2M.
Cormorant Asset Management first reported a position in Inspire Medical Systems in Q2 2018 and held it in 14 quarters.
Cormorant Asset Management's Inspire Medical Systems position peaked at $18.8M in Q4 2020.
288 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2021.

Based on Cormorant Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.